Vorizol Injection 200 mg/vial contains Voriconazole 200 mg, a potent broad-spectrum triazole antifungal agent used for the treatment and prevention of serious invasive fungal infections. This parenteral formulation is particularly useful in patients who cannot take oral medication or require rapid systemic antifungal therapy, such as those in intensive care units, immunocompromised patients, or those with gastrointestinal disorders that limit absorption.
Voriconazole works by inhibiting fungal cell membrane synthesis, leading to impaired growth and death of pathogenic fungi. Vorizol Injection 200 mg/vial is essential for managing life-threatening fungal infections, including invasive aspergillosis, systemic candidiasis, and rare fungal infections caused by Fusarium or Scedosporium species.
Voriconazole 200 mg per vial (for intravenous use)
Voriconazole, the active ingredient in Vorizol Injection, exerts its antifungal effects by:
Inhibiting fungal cytochrome P450 enzyme (14α-sterol demethylase) – Blocks the conversion of lanosterol to ergosterol, a key component of the fungal cell membrane.
Disrupting cell membrane synthesis – Increases fungal cell permeability, leading to cell death.
Fungistatic and fungicidal effects – Depending on species and concentration, it either halts fungal growth or kills the pathogen.
Broad-spectrum coverage – Effective against Aspergillus spp., Candida spp., Fusarium spp., and Scedosporium spp.
Rapid tissue penetration – Achieves therapeutic concentrations in plasma, lungs, CNS, eyes, and other tissues for systemic infections.
This dual action ensures rapid control of severe fungal infections and reduces morbidity and mortality in critically ill patients.
Vorizol Injection 200 mg/vial is indicated for:
Invasive aspergillosis – Especially in immunocompromised or critically ill patients
Systemic candidiasis – Including bloodstream infections and esophageal candidiasis
Fusarium and Scedosporium infections – Where alternative therapies are ineffective
Prophylaxis in high-risk patients – Such as those undergoing stem cell transplantation or chemotherapy
Other severe systemic fungal infections – As directed by an infectious disease specialist
Adults: Typical dosing is 6 mg/kg IV every 12 hours on the first day (loading dose), followed by 4 mg/kg IV every 12 hours.
Pediatrics: Dose is weight-based; consult a physician for precise calculation.
Preparation: Reconstitute vial according to instructions and dilute before IV infusion. Administer slowly over 1–2 hours to minimize adverse effects.
Duration: Determined by severity and site of infection; treatment may extend weeks to months.
Monitoring: Regular monitoring of liver function, renal function, plasma drug levels, and ECG is recommended during therapy.
Provides rapid and potent antifungal activity for life-threatening infections
Suitable for patients unable to take oral medications
Broad-spectrum coverage against Candida, Aspergillus, Fusarium, and Scedosporium
Effective for both treatment and prophylaxis in high-risk patients
Supports improved clinical outcomes in immunocompromised and critically ill patients
Use cautiously in patients with hepatic or renal impairment
Avoid co-administration with CYP450-interacting drugs and QT-prolonging agents
Monitor for hepatotoxicity, neurological effects, and visual disturbances
Pregnancy and breastfeeding: Only use if clearly indicated
Strict adherence to dosing reduces resistance and treatment failure
Common side effects:
Nausea, vomiting, diarrhea
Headache, dizziness
Visual disturbances, including blurred vision or color perception changes
Mild liver enzyme elevation
Serious side effects:
Severe hepatotoxicity
Cardiac arrhythmias due to QT prolongation
Allergic reactions (rash, swelling, or difficulty breathing)
Seek immediate medical attention for hepatotoxicity, severe visual disturbances, or hypersensitivity reactions.
Store between 2–8°C; protect from light
Keep vials in original packaging until use
Do not freeze
Keep out of reach of children
Vorizol Injection 200 mg/vial provides rapid, broad-spectrum antifungal therapy, essential for severe systemic fungal infections, especially in critically ill or immunocompromised patients who require effective intravenous treatment.
Login Or Registerto submit your questions to seller
No none asked to seller yet